The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
Open accessAbstract
Non–alcohol–induced steatohepatitis (NASH) is characterized by elevated serum aminotransferase activities with hepatic steatosis, inflammation, and occasionally fibrosis that may progress to cirrhosis. No established treatment exists for this potentially serious disorder. Our aim was to conduct a pilot study to evaluate the safety and estimate the efficacy of ursodeoxycholic acid (UDCA) and clofibrate in the treatment of NASH. Forty patients were diagnosed with NASH based on a compatible liver biopsy with other causes of liver disease, including alcohol abuse, excluded by history, serum tests, and use of ultrasound. Twenty–four patients received 13 to 15 mg/kg/d of UDCA for 12 months. Sixteen patients with hypertriglyceridemia were placed on clofibrate, 2 g/day for 12 months. Twenty–five women and 15 men entered the study. Six of 40 patients (15%) withdrew because of side effects. Four additional patients were withdrawn because of noncompliance; one of them later required liver transplantation. In the UDCA group, the decreases in mean serum levels of alkaline phosphatase, alanine transaminase (ALT), and γ–glutamyl transpeptidase (GGT) as well as histological grade of steatosis were significant. Among the patients treated with clofibrate, no change from baseline was found in mean ALT, aspartate transaminase (AST), GGT, bilirubin, triglycerides, and cholesterol, or in histological grade of steatosis, inflammation, or fibrosis after 12 months of treatment as compared with entry. Alkaline phosphatase activities decreased significantly from baseline. Despite the known lipid–lowering effects of clofibrate, it did not appear to be of clinical benefit in the treatment of NASH in this 1–year pilot study. However, treatment of NASH with UDCA for 12 months resulted in significant improvement in alkaline phosphatase, ALT, GGT, and hepatic steatosis. The possible benefit of UDCA therapy should be further investigated in the context of a randomized, controlled trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Self-citationPowell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
1983 metropolitan height and weight tables.
(1983) · PubMed · Cited by 727
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 550
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Self-citationAlcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 483
Hepatic effects of dietary weight loss in morbidly obese subjects
Andersen, T., Gluud, C., Franzmann, M.-B., & Christoffersen, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90942-5 · Cited by 407
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
SchÖLmerich, J., Becher, M.-S., Schmidt, K., Schubert, R., Kremer, B., Feldhaus, S., & Gerok, W. (1984) · Hepatology · doi:10.1002/hep.1840040416 · Cited by 294
Nonalcoholic Steatohepatitis in Obesity: A Reversible Condition
ERIKSSON, S., ERIKSSON, K., & BONDESSON, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02733.x · Cited by 198
Nonalcoholic fatty liver disease: What nurses need to know
(2020) · Nursing · doi:10.1097/01.nurse.0000656496.00204.01 · Cited by 179
Leuschner, U., Leuschner, M., Sieratzki, J., Kurtz, W., & H�bner, K. (1985) · Digestive Diseases and Sciences · doi:10.1007/bf01308413 · Cited by 176
Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
Itoh, S., Yougel, T., & Kawagoe, K. (1987) · PubMed · Cited by 174
Liver morphology in morbid obesity: a literature study.
Andersen, T., & Gluud, C. N. (1984) · PubMed · Cited by 129
Hepatic Free Fatty Acids in Alcoholic Liver Disease and Morbid Obesity
Mavrelis, P. G., Ammon, H. V., Gleysteen, J. J., KOMOROWSKI, R. A., & Charaf, U. K. (1983) · Hepatology · doi:10.1002/hep.1840030215 · Cited by 106
Effect of different doses of ursodeoxycholic acid in chronic liver disease
Podda, M., Ghezzi, C., Battezzati, P. M., Bertolini, E., Crosignani, A., Petroni, M. L., & Zuin, M. G. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01536665 · Cited by 77
Acosta, D., & Wenzel, D. G. (1974) · Atherosclerosis · doi:10.1016/0021-9150(74)90023-9 · Cited by 68
Lipid content in the liver of fatty metamorphosis of pregnancy.
Eisele, J. W., Barker, E. A., & Smuckler, E. A. (1975) · PubMed Central · Cited by 45
Follow-up study of refractory obesity treated by fasting.
MacCuish, A. C., Munro, J., & Duncan, L. J. P. (1968) · BMJ · doi:10.1136/bmj.1.5584.91 · Cited by 41
Cairns, S. R., KARK, A. E., & Peters, T. J. (1986) · Journal of Clinical Pathology · doi:10.1136/jcp.39.6.647 · Cited by 34
Nonalcoholic Fatty Liver Disease
Seth, A., & Balakrishnan, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48662-8_5 · Cited by 31
LIPID CONTENT IN THE LIVER OF FATTY METAMORPHOSIS OF PREGNANCY
Eisele, J. W., Barker, E. A., & Smuckler, E. A. (1976) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197607000-00008 · Cited by 19
Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver.
Massarrat, S., Jordan, G., Sahrhage, G., Korb, G., Jc, B., & Dölle, W. (1974) · PubMed · Cited by 18
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Metadata
- Authors
- Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B.
- Venue
- Hepatology
- Published
- 1996-06
- Volume
- 23
- Issue
- 6
- Pages
- 1464-1467
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2076204761
- Cited by
- 566
- References
- 25
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.